SYRE
#993
Spyre Therapeutics, Inc. - Common Stock
102.1 7 USD
+0.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+3.25%
Variación mensual
+22.30%
Variación en los últimos 6 meses
+207.74%
Cambio anual
+327.31%
Cierres anteriores
98.9 5
Open
101.6 4
Mínimo
101.1 5
High
102.5 8
Volumen
1 080
Financials
- Market Capitalization 8.87 B
- Employee 112
- Founded 2013
- CEO N/A
- Website www.spyre.com
- Headquarter Delaware, United States
- FIGI BBG0067L94B2
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-23.79
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 990 |  CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 83.89 USD | +0.22% | +0.53% | +137.92% | +104.11% | 8.85 B USD | ||
| 992 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 135.67 USD | +3.35% | -3.14% | +20.24% | +80.58% | 8.73 B USD | ||
| 1007 |  TGTX TG Therapeutics, Inc. - Common Stock | 56.42 USD | +2.79% | -1.42% | +12.52% | +47.35% | 8.64 B USD | ||
| 1022 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.27 USD | +0.23% | +0.77% | +55.78% | +150.55% | 8.31 B USD |